Literature DB >> 2721318

CCK receptors in release of pancreatic polypeptide (PP) in dogs.

S J Konturek1, P Konturek, W Bielański, K Szewczyk.   

Abstract

Pancreatic polypeptide (PP) is released after ingestion of protein-fat meals and following administration of some gut hormones (CCK and bombesin), but the hormonal contribution to the physiological release of PP has not been elucidated. We used specific and potent CCK-receptor antagonist, L-364,718, administered intravenously in a dose of 0.5 mumol/kg or intraduodenally in a dose of 2 mumol/kg to assess the role of CCK in the release of PP. Exogenous CCK-8 infused intravenously in gradually increasing doses (12.5-400 pmol/kg/hr) caused a dose-dependent increase in plasma PP from basal 28 +/- 4 pM to 136 +/- 18 pM, and this PP increase was completely suppressed by both intravenous and intraduodenal administration of L-364,718. Meat feeding caused a dramatic increase in plasma PP from a basal level of 26 +/- 4 pM to a peak of about 190 +/- 32 pM, and the pretreatment with intravenous or intraduodenal L-364,718 reduced this PP increase by about 60%. Duodenal perfusion with oleate (0.12-4.0 mmol/hr) or L-Trp (0.12-4.0 mmol/hr) also increased plasma PP, reaching, respectively, 180 +/- 28 pM and 76 +/- 6 pM. Pretreatment with intravenous or intraduodenal L-364,718 completely abolished the plasma PP responses to oleate and L-Trp. Bombesin (100 pmol/kg/hr) raised plasma PP to the level similar to that achieved by meat feeding and L-364,718 given intravenously or intraduodenally blocked completely these plasma PP increments.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2721318     DOI: 10.1007/BF01540269

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  31 in total

1.  A newly recognized pancreatic polypeptide; plasma levels in health and disease.

Authors:  J C Floyd; S S Fajans; S Pek; R E Chance
Journal:  Recent Prog Horm Res       Date:  1976

2.  Effect of cholecystokinin receptor antagonist on pancreatic responses to exogenous gastrin and cholecystokinin and to meal stimuli.

Authors:  S J Konturek; J Tasler; M Cieszkowski; K Szewczyk; M Hladij
Journal:  Gastroenterology       Date:  1988-04       Impact factor: 22.682

3.  Release of pancreatic polypeptide in humans by infusion of cholecystokinin.

Authors:  J Lonovics; S Guzman; P Devitt; K E Hejtmancik; R L Suddith; P L Rayford; J C Thompson
Journal:  Gastroenterology       Date:  1980-11       Impact factor: 22.682

4.  Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.

Authors:  R A Liddle; I D Goldfine; M S Rosen; R A Taplitz; J A Williams
Journal:  J Clin Invest       Date:  1985-04       Impact factor: 14.808

5.  Pancreatic polypeptide - a postulated new hormone: identification of its cellular storage site by light and electron microscopic immunocytochemistry.

Authors:  L I Larsson; F Sundler; R Håkanson
Journal:  Diabetologia       Date:  1976-07       Impact factor: 10.122

6.  Effect of pancreatic polypeptide on canine migrating motor complex and plasma motilin.

Authors:  K E Hall; N E Diamant; T Y El-Sharkawy; G R Greenberg
Journal:  Am J Physiol       Date:  1983-08

7.  Pancreatic polypeptide and vagal stimulation of gastric and pancreatic secretion in dogs.

Authors:  J S Swierczek; S J Konturek; J Tasler; J Jaworek; M Cieszkowski
Journal:  Hepatogastroenterology       Date:  1981-08

8.  Role of secretin and CCK in the stimulation of pancreatic secretion in conscious dogs. Effects of atropine and somatostatin.

Authors:  S J Konturek; J W Konturek; C B Lamers; J Tasler; J Bilski
Journal:  Int J Pancreatol       Date:  1987-08

9.  The release of pancreatic polypeptide by CCK-octapeptide and some analogues in the dog.

Authors:  F D Meyer; K Gyr; W H Häcki; C Beglinger; L Jeker; L Varga; L Kayasseh; D Gillessen; G A Stalder
Journal:  Gastroenterology       Date:  1981-04       Impact factor: 22.682

10.  Structural features of various proglumide-related cholecystokinin receptor antagonists.

Authors:  R T Jensen; Z C Zhou; R B Murphy; S W Jones; I Setnikar; L A Rovati; J D Gardner
Journal:  Am J Physiol       Date:  1986-12
View more
  3 in total

1.  Role of cholecystokinin in bombesin- and meal-stimulated pancreatic polypeptide secretion in dogs.

Authors:  J B Jansen; A J de Jong; M V Singer; W Niebel; L C Rovati; C B Lamers
Journal:  Dig Dis Sci       Date:  1990-09       Impact factor: 3.199

Review 2.  Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target.

Authors:  Laurence J Miller; Aditya J Desai
Journal:  Trends Endocrinol Metab       Date:  2016-05-04       Impact factor: 12.015

3.  The influence of somatostatin on glucagon and pancreatic polypeptide secretion in the isolated perfused human pancreas.

Authors:  R Kleinman; R Gingerich; G Ohning; H Wong; K Olthoff; J Walsh; F C Brunicardi
Journal:  Int J Pancreatol       Date:  1995-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.